ARHTF yields 14388.49% · PFE yields 6.20%● Live data
📍 ARHTF pulled ahead of the other in Year 1
Combined, ARHTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ARHTF + PFE for your $10,000?
ARHT Media Inc., together with its subsidiaries, engages in the development, production, and distribution of digital human holograms and content worldwide. The company's patented technology allows for the capture, transmission, and display of the digital human holograms delivered to either an in-person or online audience, which are beamed onto virtually any stage in the world and displayed live for two-way interaction with an audience. Its products include technology rented and used for various one-off events, such as a product launch, client meetings, sales conferences, doctor training, 5G showcases, press events, and others; and Capture Studio System, an end to end solution used to capture a subject for the purpose of presenting them holographically or digitally. The company also offers HoloPresence Display, which is used for events, meetings, conferences, and other temporary installations; HoloPod Display, a permanent presentation solution for all visual communication needs; and ARHT Engine hardware and software. Further, it provides various services, including consulting, project management, training in the use of software and technology, and content creation for events. The company was founded in 2012 and is headquartered in Toronto, Canada.
Full ARHTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.